Cargando…
Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice
Many acute myeloid leukaemias (AMLs) express high levels of BCL-2 and MCL-1, especially after therapy. To test the impact of these anti-apoptotic proteins on AML development and treatment, we used haemopoietic reconstitution to generate MLL-AF9 AMLs expressing BCL-2 or Mcl-1 transgenes. AMLs with el...
Autores principales: | Anstee, Natasha S., Bilardi, Rebecca A., Ng, Ashley P., Xu, Zhen, Robati, Mikara, Vandenberg, Cassandra J., Cory, Suzanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6748137/ https://www.ncbi.nlm.nih.gov/pubmed/30470795 http://dx.doi.org/10.1038/s41418-018-0209-1 |
Ejemplares similares
-
Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice
por: Bilardi, Rebecca A, et al.
Publicado: (2016) -
Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells
por: Mensink, Mark, et al.
Publicado: (2018) -
MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis
por: Nguyen, Hai Vu, et al.
Publicado: (2023) -
Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice
por: Anstee, Natasha S, et al.
Publicado: (2017) -
Protocol to establish a stable MLL-AF9_AML mouse model
por: Lu, Jun, et al.
Publicado: (2022)